A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

Clinical trial NCT07284511 · RECRUITING

Trial details

NCT number: NCT07284511
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Type 1 Diabetes Mellitus T1D T1DM T1DM - Type 1 Diabetes Mellitus

Start date: 2026-05-19
Primary completion: 2028-01-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.